Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
417M
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
135M
-
Shares change
-
-11M
-
Total reported value, excl. options
-
$414M
-
Value change
-
-$32.3M
-
Put/Call ratio
-
0.46
-
Number of buys
-
88
-
Number of sells
-
-87
-
Price
-
$3.06
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2025
244 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q3 2025.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 135M shares
of 417M outstanding shares and own 32.48% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (30.4M shares), VANGUARD GROUP INC (23.1M shares), GEODE CAPITAL MANAGEMENT, LLC (9.72M shares), STATE STREET CORP (8.95M shares), RENAISSANCE TECHNOLOGIES LLC (7.71M shares), PNC Financial Services Group, Inc. (4.46M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.27M shares), NORTHERN TRUST CORP (3.37M shares), Divisadero Street Capital Management, LP (2.77M shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.7M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.